ID |
http://id.who.int/icd/entity/1165131409 |
Preferred Name |
toxoplasmose pulmonaire due à toxoplasma gondii |
Definitions |
In immunodeficient patients, toxoplasmosis most often occurs in persons with defects in T cell–mediated immunity such as those receiving corticosteroids, anti–tumor necrosis factor (TNF) therapies, or cytotoxic drugs and those with hematologic malignancies, organ transplants, or acquired immunodeficiency syndrome (AIDS). Pulmonary toxoplasmosis in the immunodeficient patient may appear in the form of interstitial pneumonitis, necrotizing pneumonitis, consolidation, pleural effusion, or empyema, or all of these.[1] AIDS patients with Toxoplasma pneumonia present with cough, dyspnea, and fever. As toxoplasmosis is generally seen only in advanced HIV infection with CD4 counts below 100, the majority of AIDS patients who develop toxoplasma pneumonia already have had previous HIV-associated opportunistic infections. In solid organ transplant patients, this is most commonly due to transplantation of a toxoplasma-seropositive lung or heart into a seronegative recipient, resulting in primary pulmonary disease. In bone marrow transplant patients, pulmonary toxoplasmosis occurs in 0.28% to 0.45% of patients. Unlike solid organ transplant patients, most of these patients have reactivation, not primary disease.[2] Source: [1]Montoya JG, et al. Toxoplasma gondii. In: edited by Mandell GL, Bennett JE, Dolin R, Mandell, Douglas, and Bennett’s principles and practice of infectious diseases7th ed. Philadelphia: Churchill Livingstone, 2010.3495-3526 [2]McCarthy J, et al. PARASITIC LUNG INFECTIONS. In: Robert J. Mason BJ et al. editors. Murray & Nadel's textbook of respiratory medicine. 5th ed. Philadelphia: Saunders Elsevier: 2010. p.661-698 |
Type |
http://www.w3.org/2002/07/owl#Class |
comment | chez les patients immunodéprimés, la toxoplasmose se manifeste le plus souvent sous la forme d'une pneumonite interstitielle, d'une pneumonite nécrosante, d'une consolidation, d'un épanchement pleural ou d'un empyème, ou tout cela. [1] les patients atteints de la pneumonie à toxoplasma en présence de toux, de dyspnée et de fièvre. comme la toxoplasmose n'est généralement observée que chez les patients atteints d'une infection à vih avancée dont le nombre de cas de cd4 est inférieur à 100, la majorité des patients atteints du sida qui développent une pneumonie à toxoplasma ont déjà eu des infections opportunistes associées au vih, ce qui se traduit par une maladie pulmonaire primitive. chez les patients ayant reçu une greffe de moelle osseuse, une pneumonie à toxoplasma présente avec la toux, la dyspnée et de la fièvre. comme σε ανοσοανεπάρκεια ασθενείς, τοξοπλάσμωση των πνευμόνων πιο συχνά παρατηρείται σε άτομα με ελαττώματα σε t cell μεσολαβείται ασυλία όπως εκείνες που λαμβάνουν corticosteroids, παράγοντα νέκταρ όγκου (tnf) θεραπεύει, ή κυτταροτοξικά φάρμακα και εκείνες με αιματολογικές κακοήθειες, μεταμοσχεύσεις οργάνων, ή το επίκτητο σύνδρομο ανοσοανεπάρκειας (aids) .πνευμονική τοξοπλάσμωση στον ανοσοανεπάρκεια ασθενή μπορεί να εμφανιστεί με τη μορφή της διάμεση πνευμονιitis, νεκροποίηση πνευμονίτιδα, ενοποίηση, υπεζωκοτική συλλογή, ή εμύema, ή όλα αυτά. [1] βοηθά τους ασθενείς με τοξοπλάσμμα από τοξοπλάσμωση, δύσπνοια και πυρετό. όπως τοξοπλάσμωση παρατηρείται γενικά μόνο σε προχωρημένη hiv λοίμωξη με cd4 μετράει κάτω στα 100, η πλειοψηφία των ασθενών που αναπτύσσουν τοξοπλ In immunodeficient patients, toxoplasmosis most often occurs in persons with defects in T cell–mediated immunity such as those receiving corticosteroids, anti–tumor necrosis factor (TNF) therapies, or cytotoxic drugs and those with hematologic malignancies, organ transplants, or acquired immunodeficiency syndrome (AIDS). Pulmonary toxoplasmosis in the immunodeficient patient may appear in the form of interstitial pneumonitis, necrotizing pneumonitis, consolidation, pleural effusion, or empyema, or all of these.[1] AIDS patients with Toxoplasma pneumonia present with cough, dyspnea, and fever. As toxoplasmosis is generally seen only in advanced HIV infection with CD4 counts below 100, the majority of AIDS patients who develop toxoplasma pneumonia already have had previous HIV-associated opportunistic infections. In solid organ transplant patients, this is most commonly due to transplantation of a toxoplasma-seropositive lung or heart into a seronegative recipient, resulting in primary pulmonary disease. In bone marrow transplant patients, pulmonary toxoplasmosis occurs in 0.28% to 0.45% of patients. Unlike solid organ transplant patients, most of these patients have reactivation, not primary disease.[2] Source: [1]Montoya JG, et al. Toxoplasma gondii. In: edited by Mandell GL, Bennett JE, Dolin R, Mandell, Douglas, and Bennett’s principles and practice of infectious diseases7th ed. Philadelphia: Churchill Livingstone, 2010.3495-3526 [2]McCarthy J, et al. PARASITIC LUNG INFECTIONS. In: Robert J. Mason BJ et al. editors. Murray & Nadel's textbook of respiratory medicine. 5th ed. Philadelphia: Saunders Elsevier: 2010. p.661-698 |
IRI | |
icd11Chapter | 01 |
broaderTransitive | http://id.who.int/icd/entity/592503877 |
prefLabel | toxoplasmose pulmonaire due à toxoplasma gondii |
mms | |
browserUrl | NA |
icd11Code | 1F57.2 |
label | πνευμονική τοξοπλάσμωση οφείλεται σε τοξοπλάσμωση gondii Pulmonary toxoplasmosis due to Toxoplasma gondii toxoplasmose pulmonaire due à toxoplasma gondii toksykoplazmoza płuc z powodu gondii toksykoplazmy Lungentoxoplasmose aufgrund von Toxoplasma gondii |
subClassOf | http://id.who.int/icd/entity/592503877 |
Delete | Subject | Subject Sort | Archive Sort | Author | Type | Created | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No notes to display |